4′-ethynyl-2-fluoro-2′-deoxyadenosine

We are 4′-ethynyl-2-fluoro-2′-deoxyadenosine CAS:865363-93-5 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests


Product Name: 4'-ethynyl-2-fluoro-2'-deoxyadenosine
Synonym: 2'-deoxy-4'-C-ethynyl-2-fluoro-Adenosine; EFdA; MK-8591
Cas No.: 865363-93-5
Formula: C₁₂H₁₂FN₅O₃
MW: 293.25
EINECS No.:N.A
HS Code: 2938909090

UN No.: N.A
Hazard class: Non-dangerous goods
 
Specification

 
Application
Pharmaceutical intermediate.
 
Packaging
25 kg/barrel, can also be packaged according to customer requirements. 
 
Storage
Store in a cool, ventilated warehouse. 
Keep away from fire and heat. 
The temperature should not exceed 37 °C. 




Related News: The Company’s immuno-regulatory product candidates include ProTmune, a pharmacologically modulated, donor cell graft that is currently being evaluated in a Phase 2 clinical trial for the prevention of graft-versus-host disease, and a myeloid-derived suppressor cell immunotherapy for promoting immune tolerance in patients with immune disorders. Fate Therapeutics is headquartered in San Diego, CA.Retinyl acetate CAS:127-47-9 Refers to the active pharmaceutical ingredients used in the manufacture of original research drugs (patent drugs or innovative drugs). It mainly meets the needs of international original research drug companies and emerging biopharmaceutical companies for innovative drugs at various stages of clinical research, registration approval and commercialization of drugs. Contains advanced intermediates used in the manufacture of this drug substance that need to be regulated by regulatory authorities.141-90-2 The data will be updated at the upcoming 2019 ASH Annual Meeting next week.1-Bromo-3-methoxypropane CAS:36865-41-5 The data will be updated at the upcoming 2019 ASH Annual Meeting next week.Corden Pharma group companies offer contract development and contract manufacturing for advanced pharmaceutical intermediates, APIs, and drug product formulations with more than 1,500 individuals supporting their customers with specialized technologies in all international markets.